| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $56.6M | +21.1% |
| Cost of Revenue | $16.7M | +6.4% |
| R&D Expense | $9.6M | -24.4% |
| SG&A Expense | $119.0M | -0.5% |
| Operating Income | -$83.4M | +20.9% |
| Pre-tax Income | -$72.8M | +36.3% |
| Income Tax | -$1K | -107.7% |
| Net Income | -$72.8M | +36.3% |
| EPS (Basic) | -$0.56 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.3M | -16.6% |
| Accounts Receivable | $26.4M | -23.6% |
| Inventory | $2.4M | -42.2% |
| Current Assets | $41.5M | -11.2% |
| Total Assets | $93.0M | -8.2% |
| Current Liabilities | $259.6M | +3.7% |
| Total Liabilities | $285.6M | +4.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $19.3M | +193.4% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$2.7M | -710.6% |
| Financing Cash Flow | -$18.1M | -176.9% |
| Free Cash Flow | $19.3M | +193.3% |
| +56.3% |
| EPS (Diluted) | -$0.61 | +52.3% |
| Stockholders' Equity |
| -$192.6M |
| -11.4% |